" class="no-js "lang="en-US"> Hakim Yadi - Medtech Alert
Thursday, March 28, 2024
Hakim Yadi

Hakim Yadi

About Hakim Yadi

Hakim is a Co-Founder and chief executive of Closed Loop Medicine.

Closed Loop Medicine is a healthcare technology company developing drug + digital combination products, transforming drug effectiveness through optimisation by providing every drug its real time digital companion. The company is currently focused on individual solutions in hypertension and sleep we aim to further develop our pipeline through the creation of additional single-prescription combination products that cater to the needs of patients suffering from chronic disease ensuring that the patient and clinician are put at the centre of our product solutions.

Hakim joined Closed Loop Medicine from the Northern Health Science Alliance Ltd, the pan-Northern health partnership which brought together for the first time 20 research-based NHS hospitals, the North’s Academic Health Science Networks and Universities to collaborate on improving health outcomes across the North.

As the founding CEO of the NHSA, Hakim was instrumental in raising the profile of the region in parliament, with investors and the media to help focus resources on improving healthcare services for the 15 million population living in the North and its eight great cities. Central to the NHSA’s mission was to raise awareness of the region’s high mortality rates and to seek national solutions to improve these morbidity levels by working with all local agencies to improve health – and therefore wealth and well-being -outcomes.

Hakim was also highly successful in working with companies in the North to attract substantial domestic and overseas investment into the region’s life science sector, one of the most vibrant in the country.

Having worked with specialist drug and digital companies all around the world, he has a deep understanding of innovation systems integration.

Hakim started his career at IMS Health before joining PA Consulting, where he co-managed the company’s translational medicine team. During his time at PA, he was seconded to the UK Government where he worked as the Chief Operations Officer and was a founding member of the UK Department of International Trade (DIT) Life Sciences Organisation (LSO). In this role, he helped to oversee the DIT’s global life science inward investment strategy.

He holds a PhD from the University of Cambridge and in 2017 he was awarded an OBE for services to Healthcare Technology and the Economy.

Related Story

Closed Loop Medicine Announces Completion of Precision Medicine Clinical Trial for Patients with High Blood Pressure

March 23 2022

Closed Loop Medicine Ltd, a leader in the development of single prescription drug plus digital […]

Closed Loop Medicine Closes £13 Million Financing

November 3 2021

Closed Loop Medicine (the “Company”), the global leader in the development of single prescription drug […]